SG11201607149WA - Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay - Google Patents

Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay

Info

Publication number
SG11201607149WA
SG11201607149WA SG11201607149WA SG11201607149WA SG11201607149WA SG 11201607149W A SG11201607149W A SG 11201607149WA SG 11201607149W A SG11201607149W A SG 11201607149WA SG 11201607149W A SG11201607149W A SG 11201607149WA SG 11201607149W A SG11201607149W A SG 11201607149WA
Authority
SG
Singapore
Prior art keywords
identifying
drug response
shift assay
thermal shift
reduced drug
Prior art date
Application number
SG11201607149WA
Other languages
English (en)
Inventor
Molina Daniel Martinez
Par Nordlund
Original Assignee
Pelago Bioscience AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pelago Bioscience AB filed Critical Pelago Bioscience AB
Publication of SG11201607149WA publication Critical patent/SG11201607149WA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
SG11201607149WA 2014-03-25 2015-03-25 Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay SG11201607149WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1405327.6A GB2524519B (en) 2014-03-25 2014-03-25 Methods for identifying a biomarker indicative of a reduced drug response using a thermal shift assay
PCT/GB2015/050895 WO2015145151A1 (en) 2014-03-25 2015-03-25 Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay

Publications (1)

Publication Number Publication Date
SG11201607149WA true SG11201607149WA (en) 2016-10-28

Family

ID=50686878

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201607149WA SG11201607149WA (en) 2014-03-25 2015-03-25 Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay

Country Status (10)

Country Link
US (1) US11480578B2 (de)
EP (1) EP3123175B1 (de)
JP (1) JP6645981B2 (de)
CN (1) CN106233144B (de)
CA (1) CA2942605C (de)
DK (1) DK3123175T3 (de)
ES (1) ES2792680T3 (de)
GB (1) GB2524519B (de)
SG (1) SG11201607149WA (de)
WO (1) WO2015145151A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2524519B (en) 2014-03-25 2019-11-06 Pelago Bioscience AB Methods for identifying a biomarker indicative of a reduced drug response using a thermal shift assay
KR101862198B1 (ko) * 2016-09-30 2018-05-30 (주)스파크바이오파마 2차원 겔 전기영동에서의 열 안정성 변화-기반 형광 차이를 이용한 표적 단백질의 규명 방법
ES2891530T3 (es) * 2016-12-20 2022-01-28 Treat4Life Ab Método para determinar mutaciones de BRAF y proteína BRAF de tipo natural mediante espectrometría de masas
US11630110B2 (en) 2017-08-18 2023-04-18 Agency For Science, Technology And Research Methods to identify protein interaction
CN113160878B (zh) * 2021-04-16 2022-06-10 西北工业大学 一种天然药物分子靶标蛋白的冷启动筛选方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9525481D0 (en) * 1995-12-13 1996-02-14 Royston M C Novel method
US6036920A (en) * 1996-05-09 2000-03-14 3-Dimensional Pharmaceuticals, Inc. Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization
IL136046A0 (en) * 1997-11-12 2001-05-20 Dimensional Pharm Inc Methods for classifying proteins
US7294472B2 (en) * 2001-03-14 2007-11-13 Caden Biosciences Method for identifying modulators of G protein coupled receptor signaling
AU2003278725A1 (en) * 2002-08-27 2004-03-19 Bristol-Myers Squibb Company Polynucleotide predictor set for identifying protein tyrosine kinase modulators
US7537891B2 (en) * 2002-08-27 2009-05-26 Bristol-Myers Squibb Company Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
US20060019284A1 (en) * 2004-06-30 2006-01-26 Fei Huang Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in lung cancer cells
US7919261B2 (en) * 2005-12-05 2011-04-05 Merck Sharp & Dohme Corp. Methods for predicting treatment response based on the expression profiles of protein and transcription biomarkers
GB0606096D0 (en) * 2006-03-27 2006-05-03 Cbmm Sa Screening method
EP2061904A2 (de) * 2006-09-06 2009-05-27 Ortho-McNeil Pharmaceutical, Inc. Biomarker zur überprüfung der reaktion auf eine c-met-behandlung
EP1918714A1 (de) * 2006-11-02 2008-05-07 Koninklijke Philips Electronics N.V. Verbindungen und verfahren zur doppel-markierung von polypeptiden zum multiplexen in massenspektrometrie
US8476081B2 (en) * 2009-09-21 2013-07-02 Janssen Pharmaceutica Nv Assay for evaluating affinity and specificity of ligand-albumin binding
WO2011050069A1 (en) * 2009-10-20 2011-04-28 Prometheus Laboratories Inc. Proximity-mediated assays for detecting oncogenic fusion proteins
US20140004530A1 (en) * 2010-12-22 2014-01-02 Cellzome Gmbh Method for the evaluation of compound-target interactions across species
US20120194522A1 (en) * 2011-02-01 2012-08-02 Life Technologies Corporation Systems and Methods for the Analysis of Protein Melt Curve Data
GB201106548D0 (en) * 2011-04-18 2011-06-01 Evitraproteoma Ab A method for determining ligand binding to a target protein using a thermal shift assahy
US9523693B2 (en) * 2011-04-18 2016-12-20 Biotarget Engagement Interest Group Ab Methods for determining ligand binding to a target protein using a thermal shift assay
US9261497B2 (en) * 2012-10-16 2016-02-16 New York University Method of treating cancer with modulators of SCFSkp2
GB2524519B (en) 2014-03-25 2019-11-06 Pelago Bioscience AB Methods for identifying a biomarker indicative of a reduced drug response using a thermal shift assay

Also Published As

Publication number Publication date
DK3123175T3 (da) 2020-05-25
CN106233144B (zh) 2019-06-21
US11480578B2 (en) 2022-10-25
US20180172697A1 (en) 2018-06-21
CA2942605A1 (en) 2015-10-01
JP2017508983A (ja) 2017-03-30
ES2792680T3 (es) 2020-11-11
GB2524519A (en) 2015-09-30
GB201405327D0 (en) 2014-05-07
EP3123175B1 (de) 2020-04-22
JP6645981B2 (ja) 2020-02-14
WO2015145151A1 (en) 2015-10-01
EP3123175A1 (de) 2017-02-01
CN106233144A (zh) 2016-12-14
CA2942605C (en) 2023-08-22
GB2524519B (en) 2019-11-06

Similar Documents

Publication Publication Date Title
IL249983A0 (en) A method for detecting a genetic variable
HK1250045A1 (zh) 用於檢測抗cd3同二聚體的基於細胞的測定
GB2522781B (en) Mark detecting method
HK1209303A1 (en) Analyte sensing system
FI3198035T3 (fi) Menetelmiä lääkevasteen ennustamiseksi
PL3201361T3 (pl) Sposoby ilościowego oznaczania pozakomórkowego DNA
GB201412977D0 (en) Single nucleotide detection method
IL246889A0 (en) A method for measuring engagement
SG10201500862RA (en) A Method for Detecting a Target Analyte
DK3128902T3 (da) Sensor til kontinuerlig analytovervågning
GB201415761D0 (en) Methods for detection of Nucleotide modification
SG11201607149WA (en) Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay
SG11201608244TA (en) Biomarkers for assessing hiv
GB201611652D0 (en) Method of detecting a condition
SG11201701046RA (en) A test strip for paper-based assay
EP3217173A4 (de) Verfahren für den nachweis einer erkrankung
GB201508832D0 (en) A method for detecting an analyte
ZA201708254B (en) Biomarkers for detection of tuberculosis risk
PL3136822T3 (pl) Sposób określania temperatury
HK1210267A1 (en) Method for the measurement of a measurement object by means of -ray fluorescence
IL232895A0 (en) A method for receiving effective training for the purpose of obtaining required information
IL252751A0 (en) Tests for btk inhibitors
HUE051239T2 (hu) Eljárás épület hõdiagnosztikájának meghatározására
HUE065422T2 (hu) Eljárás tûzálló alkotórész nem-destruktív vizsgálatára
GB201510216D0 (en) Methods for providing a prognosis of pregnancy